Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17165637 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
Conditions: Type 2 Diabetes Mellitus;   Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Duration of Treatment: 4 wk placebo run in then 6 wk active;   Drug: Comparator: atorvastatin

Indicates status has not been verified in more than two years